July 21st, 2014
Hepatitis C Virus Infection: How Are You Managing the Cost of Newer Treatments?
Recently, we have seen remarkable progress in the treatment of chronic infection with hepatitis C virus — from long courses of injectable interferon plus ribavirin to short courses of once-daily oral sofosbuvir. Not only have these shorter, more-manageable regimens proven more effective, they are substantially better tolerated. So, what’s the problem? It seems to be […]
April 2nd, 2012
Screening for hepatocellular cancer: Recommended, but should we do it?
Most gastroenterologists are aware of the increasing incidence of hepatocellular cancer (HCC) in patients with cirrhosis. Most are also aware of the updated 2011 guidelines from the American Association for Study of Liver Diseases that recommend screening many patients with cirrhosis for HCC with every 6-month ultrasound examinations. These guidelines are based largely on a […]
April 29th, 2011
Treating chronic hepatitis C: Do we finally have the answer?
Although the treatment of chronic hepatitis C virus infection has come a long way, I have been frustrated that less than half of patients are cured with current interferon/ribavirin based therapy. That is why I have been closely watching the data related to the use of protease inhibitors such as telaprevir and boceprevir. Now that the data demonstrate the remarkable […]
M. Brian Fennerty, MD
Editor-in-Chief
NEJM Journal Watch Gastroenterology
Biography | Disclosures | Summaries
Learn more about Gut Check on Gastroenterology.
NEJM Resident 360 Curbside Consults Podcast- How the Pediatric Boards Are Made with Dr. Andrew Dwyer
- Global Health, GLocal Health, and the Indian Health Service with Dr. Adriann Begay
- Immune Checkpoint Inhibitors with Dr. Kerry Reynolds
- Management of Acute Coronary Syndrome in Older Adults with Dr. Abdulla Damluji
- Culinary Medicine with Dr. Jaclyn Albin and Milette Siler, RD